Helsinn_Corporate_1

Building better todays for people with cancer

As a world leading cancer care company we aim to improve the health and quality of life for every person with cancer – today, now, when it counts.

 

At Helsinn, our vision is to help people with cancer get the most of every day. As one of the world’s leading cancer care companies, our goal is to make everything we do, from the products we choose to license to the exacting standards we apply to manufacturing, count towards improving the lives of people with cancer.

Helsinn_Corporate_2

Building better todays for people with cancer

As a world leading cancer care company we aim to improve the health and quality of life for every person with cancer – today, now, when it counts.

 

At Helsinn, our vision is to help people with cancer get the most of every day. As one of the world’s leading cancer care companies, our goal is to make everything we do, from the products we choose to license to the exacting standards we apply to manufacturing, count towards improving the lives of people with cancer.

Helsinn_Corporate_3

Building better todays for people with cancer

As a world leading cancer care company we aim to improve the health and quality of life for every person with cancer – today, now, when it counts.

 

At Helsinn, our vision is to help people with cancer get the most of every day. As one of the world’s leading cancer care companies, our goal is to make everything we do, from the products we choose to license to the exacting standards we apply to manufacturing, count towards improving the lives of people with cancer.

Helsinn_Corporate_4

Building better todays for people with cancer

As a world leading cancer care company we aim to improve the health and quality of life for every person with cancer – today, now, when it counts.

 

At Helsinn, our vision is to help people with cancer get the most of every day. As one of the world’s leading cancer care companies, our goal is to make everything we do, from the products we choose to license to the exacting standards we apply to manufacturing, count towards improving the lives of people with cancer.

 

FDA approval of Akynzeo

The U.S. Food & Drug Administration approves Helsinn's drug 'Akynzeo' for the prevention of acute and delayed phase nausea and vomiting in patients undergoing cancer chemotherapy.

 

Cancer Anorexia-Cachexia Syndrome (ESMO 2014)

Pivotal Phase III trial data for Anamorelin in Romana 1 and Romana 2 studies on non-small cell lung cancer patients with Anorexia-Cachexia shows significant increase in lean body mass, weight and improved symptoms

NEWS

Are you a healthcare professional?
Yes
No